The Netherlands Cancer Institute: Lung Neoplasms trials

The registry lists 10 Lung Neoplasms studies with The Netherlands Cancer Institute as lead sponsor. 4 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 3Phase 3 1No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung CancerRecruitingNCT07436858Phase 1
• Feasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)RecruitingNCT06691776Not applicable
• Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMERRecruitingNCT06528743Not applicable
• Osimertinib Resistance in Patients With Non-small-cell Lung Carcinoma That Have Progressed.RecruitingNCT04737382Not applicable
• Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLCWithdrawnNCT04648189Phase 2
• Cardiac Changes After Stereotactic Radiotherapy for Early Stage NSCLC Cancer or Lung MetastasisTerminatedNCT03984019Not applicable
• Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLCCompletedNCT02492568Phase 2
• Combined CFRT and SABR in Stage II and III NSCLC With Peripheral Tumors Smaller Than 5 cm.CompletedNCT01933568Phase 1
• Hippocampus Avoidance PCI vs PCICompletedNCT01780675Phase 3
• Irradiation of Large Lung Tumors or Two or More Lung Metastases SimultaneouslyCompletedNCT01543672Phase 1/2